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Abstract
Limited information is available on the transmission and spread of influenza virus in pig populations with differing
immune statuses. In this study we assessed differences in transmission patterns and quantified the spread of a
triple reassortant H1N1 influenza virus in naïve and vaccinated pig populations by estimating the reproduction
ratio (R) of infection (i.e. the number of secondary infections caused by an infectious individual) using a
deterministic Susceptible-Infectious-Recovered (SIR) model, fitted on experimental data. One hundred and ten pigs
were distributed in ten isolated rooms as follows: (i) non-vaccinated (NV), (ii) vaccinated with a heterologous
vaccine (HE), and (iii) vaccinated with a homologous inactivated vaccine (HO). The study was run with multiple
replicates and for each replicate, an infected non-vaccinated pig was placed with 10 contact pigs for two weeks
and transmission of influenza evaluated daily by analyzing individual nasal swabs by RT-PCR. A statistically
significant difference between R estimates was observed between vaccinated and non-vaccinated pigs (p < 0.05). A
statistically significant reduction in transmission was observed in the vaccinated groups where R (95%CI) was 1
(0.39-2.09) and 0 for the HE and the HO groups respectively, compared to an Ro value of 10.66 (6.57-16.46) in NV
pigs (p < 0.05). Transmission in the HE group was delayed and variable when compared to the NV group and
transmission could not be detected in the HO group. Results from this study indicate that influenza vaccines can
be used to decrease susceptibility to influenza infection and decrease influenza transmission.
Introduction
Influenza in pigs is a highly contagious viral disease of
the respiratory tract. Influenza is currently endemic in
most swine populations around the world, and the virus
tends to spread easily in susceptible populations [1-3].
Many factors contribute to the severity of the disease
including age, viral strain, concurrent infections, and
immune status of the animals [3-5].
With the detection of new influenza subtypes in the
last decade (i.e. H1N1, H1N2 and H3N2 triple reassor-
tant viruses) [6-8] in pigs and the recent appearance of
the 2009 pandemic H1N1, both human and animal
health officials have paid greater attention to flu in pigs
due to the role that pigs play in inter-species transmis-
sion [9]. The control of influenza in pigs is often accom-
plished by the use of vaccines [10]. Both inactivated
licensed commercial vaccines and autogenous licensed
inactivated vaccines are commonly used in pigs. Com-
mercial vaccines confer protection against flu infection
and disease presentation but often this protection is
only partial [11-13]. Commercial vaccines usually
include one or more isolates representative of the strains
in a region but they may not always confer protection
against the isolate infecting a specific farm or popula-
tion. On the other hand, autogenous vaccines may be
prepared with the isolate or isolates recovered from a
specific production system and restricted to use in only
that system. These vaccines have gained popularity in
the US in the past few years. Although vaccination can
result in the reduction of clinical signs and virus shed-
ding, limited information is available on the effect that
vaccination has on population susceptibility, the spread
of infection and how vaccination may prevent transmis-
sion to other species [14].
Transmission experiments and mathematical models
have been used to quantify vaccine-induced reduction
in the spread of Mycoplasma hyopneumoniae,p s e u -
dorabies virus, classical swine fever, Actinobacillus
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(EMCV), foot and mouth disease (FMDV), porcine
reproductive and respiratory syndrome virus (PRRSV),
hepatitis E virus, and porcine circovirus type 2 (PCV-
2) in pigs [15-23]. In order to quantify transmission of
a pathogen, a key parameter is the reproduction ratio
(R) of the infection which is defined as the average
number of secondary cases caused by an infectious
individual in a population during its entire infectious
period [24,25]. When R is greater than 1, an infection
c a ns p r e a di nap o p u l a t i o nb u ti fR is less than 1, the
infection will die out within a population. The estima-
tion of R can provide important information about the
potential for transmission of infection, the dynamics of
infection at the population level, and the impact of dis-
ease control strategies [15,26,27].
The reproduction ratio has been assessed for influenza
A virus in humans, birds, and horses [28-33], but R has
not been reported for influenza virus A in pigs. In this
study, a deterministic SIR model (Susceptible-Infected-
Recovered/Removed) was used to compare transmission
parameters between a non-vaccinated population and
vaccinated populations of pigs following the introduc-
tion of a non-vaccinated, infected pig with a triple reas-
sortant H1N1 influenza A virus. The introduction of
infected pigs into populations is one of the primary
modes of influenza virus transmission in field settings
and this study mimics a similar scenario. Specifically we
aimed at assessing the effect of vaccination on pig sus-
ceptibility to infection. Since different vaccines contain-
ing inactivated viruses that were either homologous or
heterologous to the challenge virus were used in this
study, an additional comparison could be made between
vaccine types. Results from this study provide relevant
information on the use of vaccination to control influ-
enza transmission, and highlight the implications of par-
tial protection may have in transmission dynamics and
risk of infection.
Materials and methods
Animals and animal housing
One hundred and ten, three-week-old cross-bred pigs
from a specific-pathogen-free (SPF) herd were obtained.
Pigs were free of infection with influenza virus, PRRS
virus, and M. hyopneumoniae. The sows had not been
vaccinated against influenza virus and all piglets were
screened at the herd of origin for influenza antibodies
using hemagglutination inhibition (HI) test and influ-
enza A Multiscreen enzyme linked immunosorbent
assay (ELISA, IDEXX FlockChek™ AI MultiS-Screen
Ab Test Kit, IDEXX Lab., Westbrook, ME, USA) prior
to the start of the study.
Pigs were randomly distributed into ten groups of
eleven pigs each and placed in separate isolation
rooms located at the University of Minnesota Animal
Research Facility (St Paul, MN, USA). Pigs were
assigned to 3 different treatment groups as follows: (i)
non-vaccinated control (NV); (ii) vaccinated with a
commercially licensed, heterologous vaccine (HE); and
(iii) vaccinated with an experimental, homologous vac-
cine (HO). There were 3 replicates for the NV and the
HO treatments and 4 replicates for the HE treatment.
Space allowance was 6.3 square feet per pig (0.58 m
2)
and the pigs were fed on the floor ad libitum and with
free access to water. Pigs were cared for according to
University of Minnesota IACUC protocol number
0908A71965.
Experimental design
Nasal swabs and blood samples were collected from all
pigs upon arrival to the research facility and tested by
real time reverse transcriptase PCR (RT-PCR), and for
antibodies by HI and influenza A Multiscreen ELISA.
Pigs were also injected once with an antibiotic per label
instructions in order to reduce bacterial contaminants
prior to the start of the study (Ceftiofur crystalline free
acid, 5.0 mg/kg body weight Excede
®,P f i z e rA n i m a l
Health, NY, USA).
Twenty-four hours post arrival all pigs were vacci-
nated according to their treatment group. Pigs in the
HE group received 2 mL intramuscularly (IM) of a com-
mercial licensed influenza vaccine (FluSure XP
®,P f i z e r
Animal Health, New York, USA). Pigs in the HO group
were similarly vaccinated with a homologous, inactivated
vaccine containing the same viral isolate as the challenge
virus. Each vaccination was repeated two weeks later.
The pigs in the NV group were injected with 2 mL of
sterile saline solution IM in the neck at 2 weeks interval.
In each room 1 of the 11 pigs (designated “seeder”)w a s
left unvaccinated to be intratracheally and intranasally
challenged with influenza and serve as a source of infec-
tion for the other pigs in the group.
Thirteen days after the second vaccination, nasal
swabs and blood samples were taken from all pigs, and
the seeder pigs were moved to a separate room for chal-
lenge. At 48 h post challenge, the seeder pigs were
placed back to each room in contact with their original
pen mates (1 seeder pig/group/replicate) until the termi-
nation of the study. To determine transmission, all pigs
were sampled daily by taking nasal swabs and observed
daily for presence of clinical signs consistent with influ-
enza. The transmission experiment ended at 14 days
post contact (dpc) or when all 10 contact pigs in a
room became influenza virus positive. At that point,
pigs were humanely euthanized with an intravenous
lethal dose of pentobarbital at the prescribed amount of
100 mg/kg (Fatal-Plus Solution
®, 250 mL, Vortech Phar-
maceuticals, Dearborn, MI, USA).
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A triple reassortant H1N1 strain A/Sw/IA/00239/04
(IA04) belonging to the b cluster used in previous stu-
dies [34-36] and isolated from field samples at the Uni-
versity of Minnesota Veterinary Diagnostic Laboratory
was used for challenge. The IA04 influenza virus was
grown in bulk quantities using Madin-Darby canine kid-
ney (MDCK) cells using standard procedures [37].
For preparation of the homologous vaccine, the same
virus IA04 was adjusted to an HA titer of 1:128/0.1 mL at
the time of inactivation by the addition of formalin at a
final concentration of 0.1%. The formalized virus was
mixed with an adjuvant mixture of mineral oil (9 parts)
and emulsifier (1 part; equal volumes of Span 85 and
Tween 85) in a 1:1 ratio and sonicated at 25W for 2-3 min.
The heterologous vaccine contained three distinct
inactivated influenza isolates and an adjuvant: A/Swine/
NorthCarolina/031/05 (H1N1), A/Swine/Missouri/069/
05 (H3N2), and A/Swine/Iowa/110600/00 (H1N1). The
H1N1 vaccine strains belonged to the g and δ groups
and were genetically distinct from the challenge strain.
A/Swine/Iowa/110600/00 (g) and A/Swine/North Caro-
lina/031/05 (δ) shared 92.2% and 66.8% HA nucleotide
similarity respectively, with IA04 (Mega 4 with Clustal
W alignment, Nucleotide Kimura’s). Serologic cross-
reactivity existed between the licensed vaccine strains
and challenge strain but was variable [35].
Virus inoculation/seeder pigs
Seeder pigs were infected intratracheally and intranasally
with a total of 2 mL of the IA04 H1N1 challenge virus
at a titer of 1 × 10
6 tissue culture infectious dose
(TCID)50/mL. Before the inoculation, all piglets were
sedated by an intramuscular injection of a dissociative
anesthetic at the recommended dose of 6.6 mg/kg (Tela-
zol
®, Fort Dodge Animal Health, Fort Dodge, IA, USA).
Success of inoculation in the seeder pigs was con-
firmed by positive influenza A RT-PCR from nasal
s w a b sa t2 4ha n da t4 8hp o s ti n o c u l a t i o n .V i r a li s o l a -
tion and titration was conducted from nasal swabs at 48
h post inoculation.
Researchers conducting the experimental infection
wore N-95 respirator masks, protective glasses and
gloves when performing this procedure and throughout
the entire study when they were accessing the pigs.
Transmission chain
Each transmission experiment consisted of ten suscepti-
ble (contacts) and one infectious pig (seeder) per group.
The initial infectious seeder pig in all groups was unvac-
cinated and challenged intratracheally and intranasally
with an H1N1 influenza virus. A pig was considered
infected and infectious when the virus could be detected
by RT-PCR from nasal swabs. Transmission experiments
ended at 14 dpc with the seeder pig, or when all the
contact pigs in a replicate became infected.
Sample processing and diagnostic tests
Nasal swabs
Nasal swabs were collected daily from individual pigs
using rayon-tipped swab applicators with Stuart’sm e d -
ium (BBL CultureSwab™ liquid, Stuart single plastic
applicator/Becton, Dickinson and Com., Sparks, Mary-
land 21152, USA). After sample collection, each nasal
swab was suspended in 2 mL of minimum essential
medium (MEM, Mediatech Inc., Manassas, VA, USA)
supplemented with 4% bovine serum albumin (BSA,
Sigma-Aldrich Co., St. Louis, MO, USA) prior to pro-
cessing for RT-PCR. The viral RNA was extracted using
the magnetic particle processor procedure (MagMAX™
Viral RNA Isolation Kit, Applied Biosystems, USA) and
subsequently tested using the procedure provided by the
USDA-NVSL for detection of influenza A virus Matrix
gene by RT-PCR [38]. The minimum detection limit of
influenza virus by this method is 10
1 TCID50/mL.
Virus isolation and titration was performed only from
the nasal swabs collected from the seeder pigs prior to
commingling, and from tissues at necropsy on MDCK
cell monolayers [37]. Supernatants showing cytopathic
effect (CPE) were titrated using ten-fold serial dilution
and expressed as a log 10 TCID50/mL calculated by the
Spearman-Kärber method [39].
Blood Samples
Blood samples were collected using venipucture of the
jugular vein. After collection serum was separated and
stored at -20°C. Sera were subsequently analyzed for the
detection of influenza virus antibodies by HI and influ-
enza A Multiscreen ELISA. HI tests were performed fol-
lowing standard procedures [40]. Samples were tested
by HI against the challenge strain (IA04), the licensed
commercial vaccine isolates g and δ (A/Sw/IA/110600/
00 and A/Sw/NC/031/2005, respectively), and H3N2 (A/
Sw/MO/069/2005 H3N2) at arrival, thirteen days after
the second vaccine, and at necropsy. Additionally, all
sera were tested using the Influenza A Multiscreen
ELISA following manufacturer’s protocols. The Influ-
enza A Multiscreen ELISA measures antibodies directed
against the nucleoprotein (NP) of influenza A viruses.
Tissues
At necropsy, lung affected by pneumonia was recorded
for each pig. Lesions were photographed, sketched on a
standard diagram, and the proportion of affected lung
assessed [41]. In addition, tissues from lung lobes of
each animal were collected for viral detection by RT-
PCR.
For histopathology, the tissues were fixed in 10% buf-
fered formalin and paraffin-embedded by standard tech-
niques. Tissue sections were stained with hematoxylin
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logic changes. Lung sections were examined for bronch-
iolar epithelial changes, and peribronchiolar and alveolar
inflammation. Lung sections were given a score from 0-
3 to reflect the severity of bronchial epithelial injury
based on previously described methods [42]. The lung
sections were scored according to the following criteria:
0, no significant lesions; 1, a few airways affected with
bronchiolar epithelial damage and light peribronchiolar
lymphocytic cuffing often accompanied by mild focal
interstitial pneumonia; 1.5, more than a few airways
affected (up to 25%) often with mild focal interstitial
pneumonia; 2, 50% airways affected often with intersti-
tial pneumonia; 2.5, approximately 75% airways affected,
usually with significant interstitial pneumonia; 3, greater
than 75% airways affected, usually with interstitial pneu-
monia. Additionally, the proportion of airways affected
in ten microscopic fields at 20 X magnification was also
recorded. A single pathologist examined all slides and
was blinded to the treatment groups.
Clinical signs
Clinical signs consistent with influenza were recorded
from day 1 to day 4 post arrival, during the 3 days after
the second vaccination, and daily from 0 dpc to the end
of experiment (14 dpc). Clinical signs of cough, dyspnea,
sneezing, nasal discharge and lethargy were recorded for
a period of 10 min/observation day in each room. Rectal
temperatures were recorded daily from 1 day prior to
commingling until necropsy. Temperatures ≥ 40°C were
considered a significant febrile response.
Statistical methods
Results from clinical signs, antibody titers, and lung
lesions were combined for each treatment group, result-
ing in 30 contact pigs in the control and homologous
groups, and 40 contact pigs in the heterologous group.
The seeder pig in each replicate was excluded from
these analyses.
To compare antibody responses before exposure and at
necropsy, log-transformed results (HI antibody titers) and
influenza A Multiscreen ELISA mean values were analyzed
using a paired t-test and results were considered statisti-
cally significant at p < 0.05. Clinical signs were evaluated
as a binomial response (0 = absence/1 = presence) by a
Fisher’s exact test and by a Generalized Estimating Equa-
tions (GEE) approach [43]. Presence or absence of each
clinical sign for each pig on a daily basis was scored as 1
or 0 respectively, and analyzed as repeated measures for
categorical data and clustered responses in each group.
Clinical signs were compared between all pigs in the HE
and NV groups via an odds ratio.
Means and standard deviations from macroscopic and
microscopic lung lesion scores were analyzed using
ANOVA. The response variables that had a statistically
significant effect (p ≤ 0.05) by treatment group were
further analyzed through pair-wise comparisons using
the Tukey-Kramer test. The analyses were performed
using SAS (SAS System, SAS Inst., Cary, North Caro-
lina, v 9.2).
Survival curves and infectious period (IP)
The cumulative percentage of contact pigs infected per
day in each group was compared by Kaplan-Meier survi-
val curves and log-Rank test using SAS and R (SAS Sys-
tem, SAS Inst., Cary, North Carolina, v 9.2 and R
Development Core Team (2009), R: A language and
environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria). Differences
between curves were further evaluated by pair wise
comparison using the Tukey-Kramer test. Pigs remain-
ing influenza PCR negative at the end of the study were
censored.
The survival curves were also used to calculate the
infectious period. The infectious period was defined as
t h et i m eb e t w e e nt h ef i r s ta n dt h el a s td a yt h a tv i r u s
could be detected from nasal swabs in a pig. Differences
in the infectious period and the average number of days
between contact exposure and the first pig detected
positive were calculated using the log-Rank test with
significant differences considered at p value < 0.05.
Estimation of the reproduction ratios (R)
The infection status of susceptible (S), infectious (I), and
recovered/removed (r), was determined on a daily basis
for all pigs. Transition of pigs from the S state to I state,
and from I state to r state was described by a determi-
nistic SIR model [44]. For each time interval Δt( t h e
interval between two consecutive samplings (i.e. one
day)), a pig was considered I if influenza virus was
detected by RT- PCR on nasal swabs, and it was consid-
ered S if influenza virus was not detected positive by
RT-PCR. When transmission occurred in a pen, S pigs
decreased by one (S-1) whereas the number of I pigs
increased by one (I+1). The transition from S to I
occurs according to the probability given by g = b S (t) I
(t) Δt, with the infection or transmission parameter b
denoting the rate at which a randomly chosen animal
had infectious contacts in the interval Δt.
To estimate the transmission parameter b,ag e n e r a l -
ized linear model (GLM) with a complementary log-log
link function and log I Δt/N as the offset variable (num-
ber of infectious pigs/total number of pigs) was used to
calculate the estimates of the transmission parameter b
by day (Δt = 1) [45]. Knowing the number of susceptible
contact pigs and the number of infectious pigs at the
start of each period Δt( S t-1,I t-1 ), the number of new
infections that appeared at the end of each period (Ct),
and the total number of animals in each period (N), the
probability that a pig became infected was 1-e
-IbΔt/N and
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was E(C)= S(1- e
-IbΔt/N) [18].
T h el o g i s t i cr e g r e s s i o nm odel cannot provide a direct
estimate of the transmission rate b, but with an alterna-
tive transformation known as the complementary log-
log we calculated b from the equation log [-log (1-E(C)/
S)] = log (b)+l o g( I Δt/N). This model is similar to the
linear model as follows: log [-log (1-E(C)/S)] = bo+b1X
where the intercept coefficient bo=l o g( b), with corre-
sponding b1 = 1 including the predictor X = log (IΔt/N)
as a fixed offset. With the transformation of log (b), the
transmission parameter b could be estimated. The
model entails some assumptions: (i) all susceptible ani-
mals are equally susceptible; (ii) all infected animals are
equally infectious; (iii) each infected pig poses an inde-
pendent risk of infection to each susceptible pig. Differ-
ences between b values were compared using chi-square
comparisons and differences were considered statistically
significant at p < 0.05.
Using the daily transmission rate b and the infectious
period of the contact infected pigs, the reproduction
ratio R of the infection was calculated for each replicate
in each group, as well as the overall R for each group of
treatment after the replicates were combined. Statisti-
cally significant differences between R estimates were
based on the existence of non-overlapping 95% confi-
dence intervals (C.I.’s). If a pig died during the study, it
was considered censored and N became N-1. All ana-
lyses were carried out in SAS (SAS System, SAS Inst.,
Cary, North Carolina, v 9.2).
In our study the GLM method was used because the
NV group had zero susceptible animals when the infec-
tion process ended, and in that situation the effect of
vaccination only can be tested by GLM analysis [25]. In
addition, the GLM method can be used to analyze data
of heterogeneous populations as is the case of our study
since contact animals were vaccinated and inoculated
animals were not.
Stochastic SIR model
A stochastic SIR model was developed using the trans-
mission and recovery parameters obtained from the pre-
viously described deterministic model and experimental
study (parameters listed in Table 1). For all stochastic
models, the initial number of infectious, susceptible, and
recovered pigs was 1, 10, and 0, similar to that of the
experimental study. In the stochastic models two events
could occur, transmission (S®I) and recovery (I®R)
within the SIR model (S®I®R). The transmission rate
(b)w a so b t a i n e df r o mt h ed e t e r m i n i s t i cm o d e la n dt h e
recovery rate (g) was obtained from the experimental
s t u d y( t h ei n v e r s eo ft h ei n f e c t i o u sp e r i o d ) .T h er a t ea t
which transmission occurred was bSI and the rate at
which recovery occurred was gI. Each replicate for
which transmission occurred in the experimental study
was modeled separately with 10 000 simulations using
the parameters obtained from the experimental determi-
nistic model. Each simulation was run until the infec-
tious process ended and a final size of the outbreak
could be assessed. The number of new cases (contact
infected susceptible individuals) observed for each simu-
lation, given the parameters listed in Table 1, was
assessed for each replicate with the initial number of
infectious, susceptible, and recovered individuals at 1,
10, and 0, respectively. The proportion and cumulative
proportion of 10 000 simulations by the number of new
cases for each replicate was displayed in graph format.
The direct method of Gillespie was used to model the
random events of transmission and recovery [46].
Table 1 Transmission parameter estimates and related 95% confidence intervals (CI) for each replicate and overall
treatment groups
GROUP Replicate IP
1 b
2 (95%CI) R
3 (95%CI) R
4 (95%CI)
NV 1 4.7 1.99 (0.97-3.59) 9.35 (4-18.7)
NV 2 4.2 4.71 (2.20-9) 19.81 (8.3-41.4) 10.66 (6.57-16.46)
a
NV 3 4.6 1.85 (0.91-3.29) 8.51 (3.2-18.3)
HE 1 4 0.12 (0.01-0.56) 0.51 (0.02-2.26)
HE 2 5 0.36 (0.13-0.77) 1.8 (0.47-3.9) 0.99 (0.39-2.09)
b
HE 3 3.5 0.09 (0.01-0.4) 0.32 (0.01-3.27)
HE 4 2.4 0.53 (0.19-1.15) 1.27 (0.21-1.74)
HO 1 0 2.2310
-6 (na-0.52) 0
HO 2 0 2.2310
-6 (na-0.52) 0 0
c
HO 3 0 2.9410
-6 (na-0.52) 0
The number of initial infectious (Io) and susceptible (So) pigs in each replicate were Io = 1 and So = 10, except for HE 4 where the So = 9.
1IP: average duration (days) of the infectious period for the contact pigs.
2b: transmission rate per day.
3Reproduction ratio R by replicate.
4Reproduction ratio R when replicates were combined by group.
a,b,cStatistically significant differences (p < 0.05).
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Serology
Pigs were both antibody and influenza virus negative at
the start of the study. Table 2 shows the levels of HI
antibody titers against the 4 selected flu strains prior to
exposure to the seeder pigs and at necropsy. Two weeks
after the second vaccination, the homologous vaccine
induced robust HI titers against the challenge strain
(IA04), but mean reciprocal titers in the HE group were
below 1:20. In contrast, the HE group had reciprocal
titers above 1:160 against the H1N1 and the H3N2
strains contained in the vaccine (IA00, NC05 and
MO05), while the mean reciprocal titers in the HO
group were below 1:40. At the end of the experiment,
HI titers against the challenge virus remained at about
the same levels in the HO group, and although a statis-
tically significant increase in mean titers in the HE
group was observed (p < 0.05), they still remained below
1:40. In the NV group, all pigs were seronegative (1<
10) before contact and at necropsy, and the lack of sero-
conversion at necropsy was most likely due to the lim-
ited time between infection and necropsy (less than 7
days) [36,47].
Mean influenza A Multiscreen ELISA s/n values (±
SD) of the contact pigs two days prior to exposure to
the seeder pigs were 0.874 ± 0.06 in the NV group,
0.538 ± 0.23 in the HE group, and 0.15 ± 0.05 in the
HO group (cut-off: positive < 0.673, negative > 0.673)
[48]. At necropsy, the mean s/n responses were 0.576 ±
0.26, 0.351 ± 0.26 and 0.162 ± 0.05 for the NV, the HE
and the HO groups respectively. Differences between
paired samples in both the NV and the HE groups
before contact and at necropsy were statistically signifi-
cant (p < 0.05), (Figure 1).
Transmission
RT-PCR test on nasal swabs
All seeder pigs were RT-PCR positive at 48 h post
inoculation and prior to comingling with the contact
susceptible pigs. At that time point, the virus titers from
nasal swabs in those pigs ranged from 3 × 10
2 to 1 ×
10
5 TCDI50/mL.
All the contact pigs (100%) in the NV group were
found RT-PCR positive by 5 dpc, while in the vaccinated
groups, 15 out of 40 pigs (37.5%) in the HE group and
none of the pigs (0%) in the HO group were positive by
RT-PCR (Table 3). Comparison of the cumulative per-
centages of contact pigs infected per day between treat-
ment groups via the log-Rank test from the Kaplan-
Meier survival analysis indicated that the percentage of
infected pigs was significantly higher in the NV group
than in the vaccinated groups (p < 0.0001), and the dis-
tributions did not overlap between 90% confidence
intervals (Figure 2).
Infectious period (IP)
The mean length of the infectious periods (i.e. time
between the first and the last day that virus could be
detected from nasal swabs (± SD)) in the seeder and in
contact pigs are shown in Table 4. The seeder pigs
remained PCR positive for an average of 5.08 ± 0.6 days
post infection (dpi) and no differences were observed
among them. The average infectious period for the con-
tact infected NV pigs was 4.5 ± 1.07 days and 3.50 ±
1.84 days for the contact infected pigs in the HE group.
The infectious period was 1 day shorter in pigs vacci-
nated with the HE vaccine than in the NV pigs, but the
difference was not statistically significant (p = 0.192).
The infectious period for the contact infected pigs in
the HO group was zero. In addition, the average num-
ber of days between exposure and the first pig detected
positive was significantly longer in pigs from the HE
group (6.87 ± 4.17) compared to the NV group (2.83 ±
1.14) (p = 0.0015).
Reproduction Ratio (R)
A summary of the transmission parameter estimates for
each replicate and treatment group are displayed in
Table 1. In the HE group, one pig was humanely eutha-
nized at 11 dpc for reasons not related to influenza and
was censored, yielding a total number of contact pigs in
that replicate of 9.
In the NV group, all contact pigs became infected and
R0 (95% confidence interval) was estimated at 10.66
(6.57-16.46). In contrast, the estimate of R was 1.00
(0.39-2.09) in the HE group, and 0 in the HO group. A
Table 2 HI titers (reciprocal geometric means) against 4 influenza strains (challenge strain IA04 (b) and the
commercial vaccine isolates: XP12H1(g), XP31H1(δ) and the XP69H3) by group of treatment
HI titers
Group IA04 XP12H1 XP31H1 XP69H3
before necropsy before necropsy before necropsy before necropsy
NV < 10 < 10 < 10 < 10 < 10 < 10 15 12
HE 14
a 33
b 307 240 229 82 494 344
HO 297 360 38 57 < 10 < 10 < 10 21
Before contact (- 2 dpc) and at necropsy (i.e. + 7 dpc for the control group/+14 dpc for the vaccinated groups).
a,b Statistically significant differences (p < 0.05).
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in the vaccinated groups (p < 0.05). The difference in
transmission rate (b) was also statistically significant
between the NV and HE groups (p < 0.0001). Transmis-
sion in the HO vaccinated pigs could not be detected in
any of the replicates. Transmission in the HE group was
observed in all replicates and although R was above 1 in
two of the four replicates, R was not statistically signifi-
cant below 1. However, there were statistically signifi-
cant differences between HE transmission rate b
replicates with differences observed between replicates
1, 2, 3 versus 4 (p < 0.001).
Stochastic SIR model
The number of new cases for 10 000 simulations was
determined given the parameters listed in Table 1 and
the starting values of S = 10, I = 1, and R = 0 for each
replicate. The stochastic models first highlighted that
within this small population, large outbreaks most com-
monly occurred given the parameters for all NV repli-
cates (Figures 3 and 4). At least 84% of the simulations
for each NV replicate yielded 10 contact infected pigs.
However, even with transmission and recovery para-
meters generating an R0 estimate much greater than 1,
simulations yielding no new cases or minor outbreaks
also occurred in approximately 15% of the simulations.
Stochastic simulations for the HE replicates (Figures 4
and 5) demonstrate that within this small population,
major outbreaks were rare and the number of new cases
was generally low compared to that of the NV repli-
cates. For all HE replicates, at least 40% of the simula-
tions yielded no new cases and a maximum of 7% of
simulations yielded 10 new cases compared to at least
84% of the simulations for the NV replicates. The distri-
bution of the number of new cases was also more vari-
able for the HE replicates compared to that of the NV
replicates in which the outbreak was either large or
small.
Clinical signs
Influenza-like clinical signs were mild in all pigs. No
pigs died during the study due to influenza infection,
and only one contact pig from the HE group had to be
removed from the study due to arthritis. The odds of a
pig displaying a clinical sign (fever, lethargy, coughing,
sneezing, nasal discharge, or dyspnea) during the first
week of exposure was significantly lower in the HE
group than in NV pigs (OR = 0.37, 95% CI 0.21-0.65,
p = 0.005).
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Figure 1 Paired influenza A Multiscreen ELISA s/n values against the nucleoprotein of influenza virus two weeks after vaccination
(prior to exposure) and at necropsy (bars represent the mean of s/n values (± SD) to influenza ■ after vaccination, □ at necropsy.
Positive s/n < 0.673; negative s/n > 0.673.
a,b and z,y Statistically significant differences between paired samples for the NV and HE groups before
exposure and at necropsy (p < 0.05).
Table 3 Number of RT-PCR positive contact pigs, per
group of treatment and replicates at the end of the
study
Treatment Replicate Positive contact
pigs
Total number of
contact pigs
Non-
vaccinated
11 0 1 0
Control 2 10 10
31 0 1 0
Vaccinated 1 1 10
Heterologous 2 5 10
32 9
a
47 1 0
10 1 0
Homologous 2 0 10
30 1 0
a One of the contact pig was removed from the group at 7 dpc.
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Page 7 of 15Macroscopic and microscopic lung lesions
NV pigs had pneumonia with areas of lung consolida-
tion at necropsy, and the mean (± SD) lung lesion score
was 8.86 ± 7.1%. Thirty-one of the 40 pigs in the HE
group and sixteen of the 30 pigs in the HO group had
some degree of lung consolidation. The mean lung
lesion score for the pigs in the HE group was signifi-
cantly higher (p ≤ 0.05) than the mean for the pigs in
the HO group (5% ± 8 vs. 1.7% ± 5.1) at necropsy.
Although the macroscopic lung lesions in the NV group
were greater than in the vaccinated groups, comparisons
were only performed between treatment groups with the
same endpoints.
The lung lesions of the NV pigs had moderate to
severe bronchoalveolar pneumonia with attenuation,
hyperplasia, moderate numbers of lymphocytes admixed
with macrophages in the epithelium, within the intra-
luminal necrotic cellular debris, and extending into the
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Figure 2 Time to infection curves for the three treatment groups.
a,bStatistically significant differences (p < 0.05) Difference between
vaccine groups (a) is statistically significant at 90% confidence level (p = 0.101) ● Censored data.
Table 4 Infectious period from seeder (S) and contact pigs (C) when all replicates were combined by group
Group Number of pigs excreting virus
a Infectious period
b (days ± SD) Days ± SD between exposure and start of excretion
c
NV S 3/3 5.66 ± 0.58 -
NV C 30/30 4.50 ± 1.07 2.83 ± 1.14
1
HE S 4/4 5.25 ± 0.5 -
HE C 15/40 3.50 ± 1.84 6.87 ± 4.17
2
HO S 3/3 4.33 ± 1.53 -
HO C 0/30 0 -
aReplicates from the same treatment were pooled.
bThe average number of days from the first until the last day that influenza virus could be detected from nasal swabs by PCR.
cAverage number of days between exposure and the first sample detected positive.
1, 2Statistically significant differences (p < 0.05).
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Page 8 of 15alveolar spaces. Some lung sections contained occasional
bacterial colonies. The overall microscopic lesion mean
score was 2.6 ± 0.48 at necropsy indicating significant
interstitial pneumonia and more than 75% of the airways
affected with bronchial epithelial damage.
The lung lesions of the heterologous vaccine treat-
ment pigs were highly variable ranging from absent to
severe. Lesions included moderate numbers of lympho-
cytes within the hyperplastic epithelium, intraluminal
cellular debris and occasional bacterial colonies. One pig
Figure 3 Number of new cases represented as the proportion of 10 000 simulations from the stochastic SIR model with initial values
of (S = 10, I = 1, R = 0) for each NV replicate.
Figure 4 Cumulative proportion of the number of new cases of 10 000 simulations from the stochastic SIR model with initial values
of (S = 10, I = 1, R = 0) for each NV and HE replicate.
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Page 9 of 15had a large abscess in one tissue section and another pig
had aspiration pneumonia. The lung lesions of the
homologous vaccine treatment pigs were absent to mini-
mal. The lungs of a few pigs had minimal to moderate
epithelial attenuation and hyperplasia with small num-
bers of lymphocytes within and surrounding the epithe-
lium. Many of the tissue sections from all three groups
had slight to moderate increases in prominence of the
peribronchiolar lymphoid tissue.
The severity of the lung lesions was scored at 1.41 ±
0.49 in the HO group, and at 1.16 ± 0.67 in the HE
group, indicating no differences in the severity of the
lesions between vaccinated groups (p = 0.09). However,
differences were statistically significant (p <0 . 0 5 )
between the vaccinated and non-vaccinated groups.
Discussion
Understanding transmission of influenza and the factors
that affect transmission is crucial for designing effective
control strategies. Vaccination is by far the most com-
mon strategy to prevent flu infections. However, little is
k n o w no nh o wv a c c i n a t i o na f f e c t st r a n s m i s s i o nw i t h i n
pig populations. The objectives of this study were to
quantify the spread of an H1N1 triple reassortant influ-
enza virus in populations of pigs by calculating trans-
mission parameters based on the outcome of
transmission experiments, and to assess the effect of
vaccine on susceptibility to influenza A virus infection
in pigs vaccinated with either a homologous or a hetero-
logous vaccine.
The reproduction ratio R, which is the expected aver-
age number of secondary infections caused by a typical
infectious individual during its entire infectious period
[24], is a measure to quantify the transmission and
spread of viruses in populations. When infection occurs
in an entirely susceptible population, the reproduction
ratio is named “basic” reproduction ratio or R0 [24].
When R is greater than 1, an infection can spread in a
population but if R is less than 1, the infection will die
out within a population. R estimates can be used to
assess the effect of vaccination or other control strate-
gies in populations.
Under the specific conditions of this study and as
expected, influenza virus spread quickly among non-
Figure 5 Number of new cases represented as the proportion of 10 000 simulations from the stochastic SIR model with initial values
of (S = 10, I = 1, R = 0) for each HE replicate.
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Page 10 of 15vaccinated pigs, and the estimated R0 in this population
was high (10.66, 95% CI 6.57-16.46). The estimated R
values in the vaccinated groups were significantly differ-
ent from the values in the NV group. In the HO vacci-
nated group R was estimated at 0, and in the HE group
R ranged from 0.32 to 1.8, with an overall estimate of 1
(95% CI, 0.39-2.09). However, R in the HE group was
not statistically significant below 1. Furthermore, statisti-
cally significant differences could be observed in the
transmission rates (b) between replicates, showing the
variability of the pigs’ response to influenza vaccination.
Despite the fact that transmission was significantly
reduced in the HE group, we cannot exclude the possi-
bility that outbreaks of influenza could occur in hetero-
logously vaccinated populations as evidenced by the
results of the stochastic model in this study and the
modeling estimates presented by de Jong et al. [49]. On
the other hand, transmission of the virus could not be
detected in the HO vaccinated pigs during the study
and R values in all replicates were significantly below 1,
suggesting that infection spread in a population vacci-
nated with a homologous vaccine could be prevented.
In our experiment, a SIR model (Susceptible-Infective-
Removed (or Recovered)) was used to describe influenza
transmission in pigs because the disease confers immu-
nity against re-infection with a homologous strain [44].
Basically, three different methods have been used to cal-
culate the infection parameters based upon experimental
data: Generalized Linear Models (GLM) [45,49], Martin-
gale Estimations [16], and Maximal Likelihood Estima-
tion based on the final size of an outbreak (FS) [32,50].
The selection of one of the three approaches depends
on the data available and the intensity of the sampling.
We focused on quantifying the effect of vaccination on
the susceptibility of contact pigs to influenza infection
instead of evaluating the effect on infectivity of vacci-
nated pigs. Transmission depends on both the infectivity
of the infected individuals and the susceptibility of the
contact pigs. In our study, we predicted that vaccination
of the seeder pigs would have influenced the number of
excreted influenza A viruses as shown in previous stu-
dies [30,35], and therefore we would not have been able
to replicate conditions of transmission relevant to field
situations where introduction of shedding animals in
vaccinated populations is common. Nevertheless further
studies are needed to determine the effect of excretion
on the infectivity of influenza vaccinated pigs.
Other experimental transmission studies with H7N7
avian influenza virus, PRRSV and Aujeszky’sd i s e a s e
were not able to correlate the amount of virus excreted
by infected pigs with increased values in the transmis-
sion parameter b [20,31,51]. In our study, the initial
infectiveness was similar in all the groups due to the use
of unvaccinated and experimentally inoculated seeder
pigs under the same experimental conditions. Also, no
statistically significant differences were observed in
TCID50 values at the time of exposure with the contact
pigs and the infectious period was similar for all seeder
pigs. Therefore, differences in transmission between
groups can be attributed to the decrease in susceptibility
of the contact pigs to become infected, and the length
of the IP between groups. The infectious period was one
d a ys h o r t e ri nt h eH Eg r o u pt h a ni nt h eN Vg r o u pa n d
that could play a role in the value of R and account for
some of the differences observed between replicates.
Overall, detection of influenza virus in the HE vacci-
nated population lasted longer than in the NV popula-
tion which also highlights the role of partially immune
populations as potential sustained reservoirs for influ-
enza infections.
R0 of influenza virus has been estimated previously in
chickens and horses. R0 was estimated at 1.6 to 3.5 and
at 208 for H5N1 and H7N7 avian influenza strains
respectively, and at 10.18 for an equine influenza strain
[28,30-32]. In these studies R was reduced to 0 in chick-
ens vaccinated with an inactivated H5N2 strain against
an H5N1, and it was also 0 in chickens vaccinated with
two inactivated H7N1 and H7N3 strains against an
H7N7 avian flu virus. In contrast, a recent study
reported that transmission of a H5N1 was not affected
by vaccination of broiler chickens and suggested that
this might have been due to the interference of maternal
immunity [33]. In horses, R was reduced to 2.4 for a
homologously vaccinated population and to 4.9 for a
heterologously vaccinated population. To our knowledge
this is the first study that has calculated R0 for influenza
A virus in pigs and R0 is within the reported values for
influenza in other species. In addition, results from our
study also suggest that vaccination of pigs can be used
to reduce their level of susceptibility, although a degree
of virus spread can still take place in populations with
immunity.
The reproduction ratio estimates obtained from the
deterministic model provide useful threshold values and
rates, while stochastic models allow one to investigate
estimated outcomes and probabilities such as the num-
ber of new cases. Stochasticity is important to consider
when dealing with small populations, such as the popu-
lation reflected in this experimental study. Stochastic
models can also be used to complement deterministic
models and to assess whether major inferences are com-
parable across the two different approaches.
From the deterministic models, R0 estimates for the
NV replicates ranged from 8.51 to 19.81. Therefore, fol-
lowing the introduction of one typical infected pig into
a completely susceptible population, 9 to 20 secondary
cases can be expected due to the typical infectious pig
during its entire infectious period. The NV stochastic
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influenza virus outbreaks are likely to occur in small
naïve populations following the introduction of one
infected pig. The distribution of new cases was also
similar across replicates for the NV group with either
small or large outbreaks occurring. Once the initial
infected pig transmitted the infection to a susceptible
pig, the infection chain proceeded until all or nearly all
animals were infected. These simulations likely describe
high morbidity rates observed in field settings with sus-
ceptible animals. The NV stochastic models also clearly
show that no new cases or minor outbreaks can also
occur, albeit at low frequency, in a similar population
even if R0 values are high.
The R estimates obtained from the deterministic mod-
els for the HE groups were lower than that of the NV
groups and ranged from 0.32 to 1.8. The resultant sto-
chastic models again reiterate the values obtained in the
deterministic models. The HE replicates with lower R
values (0.32 and 0.51) yielded a higher proportion of
stochastic simulations with no new cases. This finding is
expected as a lower R estimate equates to fewer second-
ary cases due to a typical infectious individual during its
entire infectious period. In all HE replicates, the propor-
tion of simulations with major outbreaks was low. On
the contrary, no new cases were observed in at least
40% of the simulations regardless of the HE replicate.
The proportion of simulations in which no new cases
were observed was greatest for those replicates in which
the R value was lower.
The impact of vaccination can be assessed in this
small population from results of the stochastic models
by comparing the NV and HE groups. In small, naïve
populations, the introduction of an influenza virus
infected pig resulted in a major outbreak and infected
all susceptible animals in greater than 84% of simula-
tions. Following vaccination with a HE vaccine in a
small population, the proportion of simulations in which
all susceptible animals become infected following the
introduction of an infected pig was very small (< 7%).
However, in the presence of HE immunity, transmission
of influenza virus to susceptible animals did occur and
i tw a sn o tp r e v e n t e di na sh i g ha s6 0 %o ft h es i m u l a -
tions as seen in HE replicate 2.
Antibodies against the hemagglutinin protein have
been correlated with strong immune response to influ-
enza and with a decrease of the likelihood of becoming
infected. However, the levels of protective HI titers
against virus replication are not easily established due to
the continuous antigenic drift of the virus and due to
that reciprocal HI titers alone may not guarantee immu-
nity or predict susceptibility [13,52,53]. Kyriakis et al.
[52], in an experimental study with pigs vaccinated with
four different commercial vaccines and challenged with
a heterologous H1N1 field isolate, found that pigs with
reciprocal HI antibodies titers ≥ 20 against the field
strain were virologicaly protected [52]. Van Reeth et al.
determined that for complete virological protection
against a heterologous strain, HI titers as high as 160
are required [13]. In those studies the viral protection
was referred to individual virus titers from lung lobes at
3 to 4 days post experimental challenge and related to
clinical signs, but not to transmission of the virus. In
our study, two weeks after the second vaccine and
before exposure to seeder pigs, pigs in the HO group
had geometric mean HI titers of 295, while the geo-
metric mean in the HE group was 14 against the chal-
lenge strain (maximum reciprocal titer was 80). The
challenge virus demonstrated low serologic cross-reac-
tivity with the antiserum induced by the heterologous
vaccine and only nine of the forty pigs from the HE
group had reciprocal HI titers of greater than 40 against
the challenge strain before exposure to the seeder pigs.
Of those, two pigs became infected and seven remained
uninfected for the duration of the study. Therefore, HI
titers against the challenge strain in HE pigs were not
able to predict the infectious status of the pigs at the
end of the study. The low immunogenicity against the
challenge virus in the HE pigs was expected and is in
agreement with other studies where pigs vaccinated with
licensed inactivated vaccines became infected when
challenged with heterologous influenza viruses
[11,12,54,55]. At the end of our study not all pigs that
had seroconverted to the challenge strain shed virus.
Eighteen of the 40 pigs in the HE group had positive HI
titers against the challenge strain at necropsy, and in 8
of the 18 pigs with HI titers ≥ 40 the virus could not be
detected from nasal swabs samples. Lack of detection
could be due to protection and lack of virus replication,
or due to the amount of virus excretion being below
detectable levels.
Another point of consideration was that our definition
in regards to “homologous” and “heterologous” was
related to the HA genetic and antigenic clustering. The
challenge strain belonged to the beta influenza H1 clus-
ter and strains in the commercial vaccine were from the
gamma and delta clusters which shared 92.2% and
66.8% HA nucleotide similarity respectively with the
challenge strain. Although it is known that cross-reactiv-
ity may exist between those clusters, this is considered
limited [35] which is likely to influence the degree of
infection. Therefore the outcome on transmission
dynamics may also be influenced by the degree of cross-
reactivity between clusters and further studies are
needed to determine the extent of this.
Differences in transmission could also be due to dif-
ferences in vaccine efficacy due to different antigen con-
centration, adjuvant used, or both factors [30,56]. A
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role of vaccine dose and adjuvant in protection against
heterologous challenge [57]. In our study, the amount of
antigen was not standardized between the homologous
and the heterologous vaccines because the HE group
was vaccinated with a commercial licensed vaccine and
i n f o r m a t i o no nt h ea n t i g e nc o n t e n tw a sn o ta v a i l a b l e .
The improved protection provided by the autogenous
vaccine was most likely due to its preparation with the
virus strain homologous to the challenge virus. It is well
documented that strain-spe c i f i ca n t i b o d yi sm o r ee f f e c -
tive than cross reactive-antibody in conferring protec-
tion against flu infection [55]. In our study, pigs that
received the homologous vaccine had no detectable
virus in nasal secretions, had a robust antibody response
to the challenge virus, and had significantly lower
macroscopic lung lesion scores compared with the pigs
that received the licensed heterologous vaccine. There
were no differences between microscopic lesions
between vaccinated groups, and histopathology in the
NV and HE group was compatible with previous influ-
enza infection. Histopathology for the HO group indi-
cated that although lesions were absent in most of the
homologous pigs, a few pigs had minimal bronchiolar
lesions that were consistent with recovery from influ-
enza infection. Despite the fact that all RT-PCR results
in the HO group were negative, we cannot conclusively
rule-out the possibility that infection took place in a few
pigs in the HO group. If infection had taken place,
infection appeared limited to the lower respiratory tract
and virus could not be detected with the methods used
in this study.
In addition, clinical signs were relatively mild in all the
infected pigs, which is similar to what has been reported
in previous studies using t h es a m ei n f l u e n z av i r u s
[12,13,36,53]. In our study, both vaccines decreased the
presence of disease and the impact of influenza infec-
tion. More importantly this study highlights the poten-
tial for influenza transmission despite the reduction of
obvious clinical signs in partially immune populations
and does not recommend the use of surveillance pro-
grams based on clinical signs in particular in partial
immune populations. Moreover, as discussed previously,
the virus can remain for extended periods of time in
partially immune populations. Such a silent spread of
influenza virus can lead to higher probabilities of trans-
mission to other herds and people as also shown by
Savill et al [58].
Overall, an important consideration in regards to inac-
tivated vaccines is whether viruses can replicate and
t r a n s m i ti nt h ep r e s e n c eo fs o m ed e g r e eo fi m m u n i t y .
Under those conditions, virus escape variants can arise
and can lead to antigenic drift, loss of vaccine efficacy,
and emergence of new strains. Subclinical infections
with virus shedding can occur in vaccinated animals,
particularly when there is a mismatch between the vac-
cine and field virus strains [12,53]. In our study, virus
replication and transmission was observed in the HE
vaccinated group which suggest the potential role of
vaccination in the establishment of enzootic infections
and predisposition to virus change. However, whether
virus changes happened as a result of vaccine immune
pressure it is beyond the scope of this study and war-
rants future studies.
A limitation of our study is the inoculation dose of the
seeder pigs that could lead to a higher shedding of influ-
enza and subsequent overestimations of R compared to
conditions that occur in the field. This study was also
limited to one licensed vaccine and one autogenous vac-
cine and the results only reflect the transmission of a
single H1N1 flu strain in a limited population. There-
fore, transmission parameters in populations vaccinated
with others vaccines and infected by different strains
would need to be evaluated to further assess influenza
transmission patterns in pigs. Additionally, the starting
conditions of this study (S = 10, I = 1, r = 0) were
designed to reflect a potential field scenario in which an
infected pig was introduced into a pen of susceptible or
vaccinated pigs. The parameters estimated in this study
may not accurately reflect transmission parameters in
differing population structures and settings.
In conclusion, transmission parameter estimates
derived from this study can be used to further under-
stand influenza transmission dynamics in naïve and
immune swine populations. In our study, transmission
to contact pigs was significantly reduced by vaccination
b u ti tc o u l dn o tb ec o m p l e t e l yp r e v e n t e dw h e nah e t -
erologous vaccine was used. Virus transmission and
replication was delayed and variable in the heterolo-
gous vaccinated group. On the other hand, transmis-
sion could not be detected in homologous vaccinated
pigs. In the heterologous vaccinated group, active
transmission took place even in the absence of clinical
signs and presence of immunity, resulting in the silent
spread of influenza virus which may contribute to the
establishment of enzootic infected populations and
increased probabilities of transmission to other herds.
Such populations can in turn also be a risk for inter-
species transmission and zoonotic infections. The
results of the present study support field observations
regarding the variability observed with influenza vac-
cines to affect transmission and spread of influenza
virus.
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